Steven Cohen Corcept Therapeutics Inc Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $22,519 - $34,645	1,025 Added 154.14%	1,690 $46,000
Q2 2023 Aug 14, 2023	SELL	$21.44 - $25.15 $40,392 - $47,382	-1,884 Reduced 73.91%	665 $14,000
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $48,940 - $62,374	2,549 New	2,549 $55,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.82B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.